Global Artesunate Tablet Market Strategic Research Report

Scope of the Report

The global Artesunate Tablet market size is predicted to grow from US$ 129 million in 2025 to US$ 191 million in 2032; it is expected to grow at a CAGR of 5.9% from 2026 to 2032.

Artesunate tablets are driven by several factors. Firstly, the global malaria control situation remains severe, especially in sub-Saharan Africa and Southeast Asia, where the incidence of malaria remains high, driving the demand for effective antimalarial drugs. Secondly, the efficacy and safety of artesunate tablets in treating malaria make them a priority choice for government procurement. Additionally, with increased international aid efforts, the market coverage of artesunate tablets continues to expand. In summary, artesunate tablets have a broad market prospect globally, attracting the attention and investment of many pharmaceutical companies.In 2024, global Artesunate tablets production reached approximately 39.5 m units, with an average global market price of around US$ 3 perunit.

Despite the broad market prospects of artesunate tablets, they also face some challenges and risks. Firstly, the global malaria control situation is complex and changeable, with severe malaria transmission in some regions, posing certain difficulties for the promotion of artesunate tablets. Secondly, the production cost of artesunate tablets is relatively high, especially in terms of raw material procurement and production processes, which may affect their market competitiveness. Additionally, in some regions, the awareness of artesunate tablets is relatively low, making promotion more challenging. Therefore, enterprises need to fully consider these challenges and risks when formulating market strategies and take corresponding measures to cope.

The downstream demand for artesunate tablets mainly comes from government procurement and international aid projects. With the increasing global emphasis on malaria control, the demand for artesunate tablets continues to grow. Additionally, private medical institutions and non-governmental organizations in some regions have also become important demanders of artesunate tablets. Overall, the downstream demand for artesunate tablets is becoming more diversified, with huge market potential.

The main raw material for artesunate tablets is artemisinin, which mainly comes from the cultivation of Artemisia annua. In recent years, the planting area of Artemisia annua has gradually expanded, ensuring the supply of raw materials for artesunate tablets. However, the cultivation of Artemisia annua is affected by factors such as climate and land, which may lead to instability in supply. Therefore, enterprises need to strengthen cooperation with planting bases in raw material procurement to ensure stable supply.

This report presents a comprehensive overview of the global Artesunate Tablet market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Monoaromatic Artesunate
• Compound Artesunate

Segment by Application

• Hospital
• Clinic
• Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Artesunate Tablet market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Hospital, Clinic, Others evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact